Identifying the Characteristics of Responders and Nonresponders in a Behavioral Intervention to Increase Physical Activity Among Patients With Moderate to Severe Asthma: Protocol for a Prospective Pragmatic Study

Carregando...
Imagem de Miniatura
Citações na Scopus
1
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
JMIR PUBLICATIONS, INC
Citação
JMIR RESEARCH PROTOCOLS, v.12, article ID e49032, 11p, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: Previous research has suggested that most adults improve their asthma control after a short-term behavioral intervention program to increase physical activity in daily life (PADL). However, the characteristics of individuals who respond and do not respond to this intervention and the medium-term response remain unknown.Objective: This study aims to (1) identify the characteristics of adult responders and nonresponders with asthma to a behavioral intervention to increase physical activity and (2) evaluate the functional and clinical benefits in the medium term.Methods: This prospective pragmatic study will include adults with moderate to severe asthma who enroll in a behavioral intervention. All individuals will receive an educational program and an 8-week intervention to increase PADL (1 time/wk; up to 90 min/session). The educational program will be conducted in a class setting through group discussions and video presentations. Behavioral interventions will be based on the transtheoretical model using counseling, incentives, and individual feedback aiming to increase participation in physical activity. Motivational interviewing and guidelines for overcoming barriers will be used to stimulate individuals to reach their goals. Pre-and postintervention assessments will include the following: PADL (triaxial accelerometry), body composition (octopolar bioimpedance), barriers to PADL (questionnaire), clinical asthma control (Asthma Control Questionnaire), quality of life (Asthma Quality of Life Questionnaire), anxiety and depression levels (Hospital Anxiety and Depression Scale), and exacerbations. ""Responders"" to the intervention will be defined as those who demonstrate an increase in the number of daily steps (& GE;2500). Results: In December 2021, the clinical trial registration was approved. Recruitment and data collection for the trial is ongoing, and the results of this study are likely to be published in late 2024. Conclusions: The intervention will likely promote different effects according to the clinical characteristics of the individuals, including asthma control, age, anxiety and depression levels, obesity, and several comorbidities. Identifying individuals who respond or do not respond to behavioral interventions to increase PADL will help clinicians prescribe specific interventions to adults with asthma.Trial Registration: ClinicalTrials.gov NCT05159076; https://clinicaltrials.gov/ct2/show/NCT05159076International Registered Report Identifier (IRRID): DERR1-10.2196/49032
Palavras-chave
Referências
  1. [Anonymous], 2000, Revista Brasileira de Cineantropometria e Desempenho Humano
  2. [Anonymous], Attribution 4.0 International (CC BY 4.0)
  3. [Anonymous], 2020, WHO Guidelines on Physical Activity and Sedentary Behaviour
  4. Botega NJ, 1995, REV SAUDE PUBL, V29, P355, DOI 10.1590/S0034-89101995000500004
  5. Bowden MG, 2013, ARCH PHYS MED REHAB, V94, P856, DOI 10.1016/j.apmr.2012.11.032
  6. BRAY GA, 1989, MED CLIN N AM, V73, P161, DOI 10.1016/S0025-7125(16)30697-6
  7. Carr LJ, 2012, J OBES, V2012, DOI 10.1155/2012/460271
  8. Carson KV, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001116.pub4
  9. Cecchi F, 2014, EUR J PHYS REHAB MED, V50, P143
  10. Chan AW, 2013, ANN INTERN MED, V158, P200, DOI 10.7326/0003-4819-158-3-201302050-00583
  11. Cordova-Rivera L, 2018, J ALLER CL IMM-PRACT, V6, P1968, DOI 10.1016/j.jaip.2018.02.027
  12. de Carvalho-Pinto RM, 2021, J BRAS PNEUMOL, V47, DOI 10.36416/1806-3756/e20210273
  13. De Oliveira MA, 2005, J ASTHMA, V42, P41, DOI 10.1081/JAS-200044772
  14. Dogra S, 2011, EUR RESPIR J, V37, P318, DOI 10.1183/09031936.00182209
  15. França-Pinto A, 2015, THORAX, V70, P732, DOI 10.1136/thoraxjnl-2014-206070
  16. Freitas PD, 2021, CHEST, V159, P46, DOI 10.1016/j.chest.2020.08.2113
  17. Freitas PD, 2019, BMC SPORTS SCI MED R, V11, DOI 10.1186/s13102-019-0128-6
  18. Freitas PD, 2017, AM J RESP CRIT CARE, V195, P32, DOI [10.1164/rccm.201603-0446OC, 10.1164/rccm.201603-0446oc]
  19. Freitas PD, 2021, EUR RESPIR J, V57, DOI 10.1183/13993003.00240-2020
  20. Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb
  21. García-Ortiz L, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-233
  22. Global Strategy for Asthma Management and Prevention, 2021, Global Initiative for Asthma
  23. Hansen ESH, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.00146-2020
  24. Hayton C, 2013, RESP MED, V107, P401, DOI 10.1016/j.rmed.2012.11.016
  25. Juniper EF, 2006, RESP MED, V100, P616, DOI 10.1016/j.rmed.2005.08.012
  26. Juniper EF, 2005, RESP MED, V99, P553, DOI 10.1016/j.rmed.2004.10.008
  27. JUNIPER EF, 1994, J CLIN EPIDEMIOL, V47, P81, DOI 10.1016/0895-4356(94)90036-1
  28. Juniper EF, 1999, EUR RESPIR J, V14, P902, DOI 10.1034/j.1399-3003.1999.14d29.x
  29. JUNIPER EF, 1992, THORAX, V47, P76, DOI 10.1136/thx.47.2.76
  30. KEENAN NL, 1992, AM J EPIDEMIOL, V135, P678, DOI 10.1093/oxfordjournals.aje.a116347
  31. Leslie E, 1999, PREV MED, V28, P20, DOI 10.1006/pmed.1998.0375
  32. Lopes AC, 2019, CHRONIC ILLN, V15, P138, DOI 10.1177/1742395317753883
  33. MARCUS BH, 1994, MED SCI SPORT EXER, V26, P1400
  34. National Clinical Guideline Centre (UK), 2010, NICE Clinical Guidelines, V101
  35. Ng LWC, 2012, CHRON RESP DIS, V9, P17, DOI 10.1177/1479972311430335
  36. NORGAN NG, 1988, ERGONOMICS, V31, P1493, DOI 10.1080/00140138808966796
  37. PATRICK K, 1994, PHYSICIAN SPORTSMED, V22, P45, DOI 10.1080/00913847.1994.11947706
  38. PROCHASKA JO, 1983, J CONSULT CLIN PSYCH, V51, P390, DOI 10.1037/0022-006X.51.3.390
  39. Reddel HK, 2009, AM J RESP CRIT CARE, V180, P59, DOI 10.1164/rccm.200801-060ST
  40. Reilly JJ, 2008, ARCH DIS CHILD, V93, P614, DOI 10.1136/adc.2007.133272
  41. Ribeiro MA, 2007, SAO PAULO MED J, V125, P115, DOI 10.1590/S1516-31802007000200010
  42. Sabit R, 2008, RESP MED, V102, P819, DOI 10.1016/j.rmed.2008.01.019
  43. Schmid JP, 2013, EUR J PREV CARDIOL, V20, P585, DOI 10.1177/2047487312444368
  44. Shi SQ, 2022, ANN TRANSL MED, V10, DOI 10.21037/atm-22-1170
  45. Spruit MA, 2015, EUR RESPIR J, V46, P1625, DOI 10.1183/13993003.00350-2015
  46. Trost SG, 2005, MED SCI SPORT EXER, V37, pS531, DOI 10.1249/01.mss.0000185657.86065.98
  47. Tudor-Locke C, 2004, SPORTS MED, V34, P1, DOI 10.2165/00007256-200434010-00001
  48. Vos T, 2020, LANCET, V396, P1562
  49. ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x